---
title: "Treatment-peripheral artery disease"
slug: "treatment-peripheral-artery-disease"
date: "2023-07-23"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[peripheral artery disease]]

# Treatment-peripheral artery disease

(JACC 2013;61:1555, Circ 2021;144:e171, JAMA 2021;325:2188)

- Risk factor modif. 
- Screen for CAD/AAA. Structured high-intensity walking
  - (JAMA 2021;325:1266).
- If sx or if asx with ABI â‰¤0.90, 
  - ASA, clopi, or ticag to â†“ D/MI/stroke (NEJM 2017; 376:32).
  - More intensive antiplt Rx â†“ both MACE & limb ischemic events (JACC 2016;67:2719).
  - Adding riva 2.5 mg bid to ASA â†“ MACE but â†‘ bleeding
    - (Lancet 2018;391:219; NEJM 2020;382:1994).
- Statins & PCSK9i â†“ MACE & limb ischemic events
  - (Circ 2018;137:338). Cilostazol (if no HF).
- Endovascular (angioplasty vs. stent) or surgical revasc if limiting/refractory sx or CLI
